ArticleJournal of skin cancer2015

Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis.

Vanessa Shih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.